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Background 
The Emergency Contraceptive Pill (ECP) is a hormone-based method providing a woman with an 
opportunity for preventing unwanted pregnancy after intercourse (Camp et al. 2003, Croxatto et al. 2004). 
ECP is an important component of the range of contraceptive services in India, where unmet family planning 
(FP)  need is about 21.3 percent (IIPS 2010). Several research studies across the globe have shown that ECP 
is safe, convenient to use, and can be effective in preventing unwanted pregnancies (WHO and JHUCCP 
2011). Findings from these research studies have encouraged several countries, including India, to make ECP 
available “over the counter” (OTC), without prescription. 
 
In India, ECP was approved and introduced into the National Family Planning Program in 2002, and made 
an OtC drug in 2005. As an OtC drug, ECP can also be stocked and distributed by paramedics and 
community health workers (CHWs). Subsequently, it has been made available by government as well as non-
governmental organizations along with existing contraceptives and promoted as a product that could be given 
in case of emergency. Data from the District Level Household and Facility Survey (IIPS 2010) show that less 
than one percent (0.5% of rural and 0.8% of urban) of married women have ever used ECP. Furthermore, 
less than one-third of surveyed unmarried women knew about ECP. Awareness among currently married 
rural women was much lower, at 24 percent, compared to urban women at 47 percent (IIPS 2010). Another 
study during the same period (Puri et al. 2007) among female college students from Chandigarh in northern 
India reported only 7.3 percent of 1,017 students knowing that ECP exists. A more recent study in a medical 
college among a smaller sample of 300 students largely from the rural population of Uttar Pradesh (UP) 
showed even lower (2%) knowledge (Nigam et al. 2010). A recent study by Population Council in rural Bihar 
found that five percent women were aware of ECP, and less than one percent had ever used it (Bhatnagar 
and Khan 2011). 
 
Several individual, community and system barriers contribute to limited ECP awareness and use, including 
lack of accurate knowledge of its mechanism and providers’ religious affiliations and fear that wide ECP  
availability may lead to increased sexual partners or early initiation of sex (Aksu et al. 2011, Rubin et al. 2006, 
Sychareun et al. 2010). Further studies have shown that providers believe easy access to ECP may lead 
women not only to be less likely to use other more reliable methods, but to initiate sex at a younger age, have 
more sexual partners, encourage sexual risk-taking, increase their risk of acquiring HIV and other STIs as well 
(Lawrence et al. 2010, Ehrale and Sarker 2011, Yam et al. 2007, Blanchard et al. 2005). Moreover, providers in 
general tend to overestimate ECP’s contraindications and side effects and do not completely support its 
provision without prescription (Aksu et al. 2011, Ehrle and Sarker 2011) A study in UP has revealed that 
CHWs have incorrect and poor knowledge about safe methods (Goel et al. 2010). 
 
Although limited in number, India studies show a lack of awareness among providers about correct 
prescribed doses of ECP and prescribed time of use (Kishore et al. 2010, Goel et al. 2010, Bhatnagar et al. 
2011). Similar to reports from other countries, providers in India also believe ECP is an essential component 
of contraceptive services but prefer it be distributed only through health care providers (Tripathi et al. 2003, 
Kishore et al. 2010). The fear that easy ECP access will increase promiscuity and misuse is found among all 
providers in India (Kishore et al. 2010). Another study finds that not only is ECP awareness low among 
CHWs such as Accredited Social Health Activists (ASHAs) (15%) but only 3.3 percent had ever been 
supplied with ECPs (Bhatnagar and Khan 2011). 
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Absence of uniform guidelines defining ‘repeated use’ and the number of times ECP can be used safely 
within the same menstrual cycle also creates hesitation about its provision among providers. Although the 
World Health Organization (WHO) (Factsheet 244, 2005) has clearly stated that repeated ECP use does not 
pose any serious health risks other than minor menstrual disturbances, most providers continue to be 
apprehensive about repeated ECP use. These fears and hesitations are further fuelled by negative media 
coverage creating an imbalanced view of side-effects as well as widespread misuse, especially by unmarried 
young girls. For example, a recent Times of India article (July 23rd 2011, Delhi edition, Appendix), “Morning-
after-pill: a medical nightmare?” portrays ECP use by young women in Delhi along with strong opinions 
against ECP by several well-known medical practitioners in the city. The article concludes with the warning 
“think twice before you pop the pill,” creating ambiguity among many readers, and such media coverage may 
discourage greater use and engender unfavorable attitudes towards ECP, not only among potential users but 
among providers and policy makers as well. 
 
The Population Council undertook this study to assess the knowledge, attitudes, and practices regarding ECP 
among providers in public and private facilities and pharmacies. This study’s objectives are: 
• Assessing providers’ knowledge of ECP’s biological mechanism; 
• Understanding providers’ knowledge and attitudes about ECP’s safety, effectiveness, and availability 
as an OtC drug; 
• Identifying providers’ definitions of ‘repeated use’ and profiling women who are ‘repeated users’ of 
ECP. 
 
This study’s findings can be used to develop intervention programs and advocacy strategies increasing 
knowledge and access to ECP. 
 
Methodology  
Quantitative survey of ECP providers 
The quantitative survey was conducted in three of the four UP cites part of the Urban Health Initiative (UHI) 
project funded by the Bill and Melinda Gates Foundation (BMGF), as well as in Delhi, the largest city in 
India, with a high volume of ECP sales. The study was initially planned in the four UP UHI cities (Lucknow, 
Aligarh, Agra and Kanpur), but initial investigation and a consultative workshop indicated that Delhi has 
India’s largest volume of ECP sales, and so Delhi replaced Kanpur. Subsequent surveys in the three UP cities 
revealed that pharmacy shops are the single most important source of ECP supply, followed by some Family 
Welfare Centers, and qualified doctors are consulted primarily in cases of problems (e.g. menstrual issues or 
ECP failure), so consequently only pharmacy shops were sampled in Delhi. 
 
Lucknow, Aligarh, and Agra are of varying sizes, with populations of diverse backgrounds and characteristics. 
UHI has developed an exhaustive list of public health sector facilities and maternity and nursing homes as 
well as a complete list of different types of providers and health workers in each city. UHI’s lists served as a 
sampling frame for the study, but in the absence of a similar systematic listing for Delhi, a sampling frame 
was developed from a census of all pharmacy shops in selected areas of Delhi. 
 
Each city was divided into four zones—east, west, north, south—and UHI’s list for that city was used to 
locate providers in each zone. The sample was purposively selected so that providers were near or in large 
residential areas, urban slums, or large institutions. A total of 315 providers were selected on the criterion of 
ever having provided ECP services and were interviewed October and November 2011 (Table 1). 
 
Table 1: Sample size of quantitative study 
Type of respondents Agra Lucknow Aligarh Kanpur Delhi Total Sample 
Qualified doctors 42 20 19 2 0 83 
Pharmacists 38 55 41 8 57 199 
Other providers 6 20 6 1 0 33 
Total  86 95 66 11 57 315 
 
 
Qualitative survey of Key Opinion Leaders 
The qualitative survey added another dimension to 
its examination of ECP in India by including in-
depth interviews (IDIs) with key opinion leaders 
(KOLs) including leading Ob/Gyn experts, senior 
officials of medical associations (such as the India 
Medical Association and Federation of 
Gynecologists and Obstetricians), senior officials of 
donor agencies, and senior program managers of the 
Ministry of Health and Family Welfare of the UP 
and federal governments. All KOLs were considered to be influential both in shaping health and FP policies 
and implementing family welfare programs or providing resources for programs and research. Altogether, 19 
KOLs were purposively selected (Table 2).  
Table 2: Area of expertise of key informants 
Area of expertise  Number 
Medical fraternity*  8 
Government officials  7 
Development organizations 3 
Manufacturing organization  1 
Total  19 
*Medical fraternity includes members of key medical 
organizations and gynecologists. The list may or may not overlap.  
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Key Findings from the Quantitative Survey  
Providers’ socio-demographic characteristics  
 
Table 3: Providers’ socio-demographic characteristics (percent) 
  Qualified 
doctors 
Other 
providers 
Pharmacists Total 
Age 
Below 25 years 1.2 0.0 15.6 10.2 
25-34 9.6 24.2 15.6 24.8 
35-44 48.2 24.2 29.1 33.7 
>45  41.0 51.5 24.1 31.4 
Average age (median) 42 45 35 39 
Gender 
Male 2.4 30.3 97.0 65.1 
Female 97.6 69.7 3.0 34.9 
Technical 
Qualifications 
Medical Doctor (MBBS) 1.2 0.0 0.0 0.3 
Medical Doctor (MD-OBGyn) 75.9 0.0 0.0 20.0 
Medical Doctor (MD-Others) 22.9 0.0 0.0 6.0 
Pharmacist 0.0 0.0 14.1 8.9 
Diploma Holder / Registered 
Nurse/ Social Worker / 
BUMS/BHMS 
0.0 48.5 3.0 7.0 
Learnt by Practice 0.0 51.5 82.9 57.8 
Total (N) 83 33 199 315 
 
Among 315 providers surveyed, 63 percent were pharmacists, 26 percent were qualified doctors, and 10 
percent were providers such as Auxiliary Nurse Midwives (ANMs), staff of social marketing agencies, and 
counselors in FP clinics attached to large public facilities. Two-thirds of providers were male and one-third 
female, due primarily to the fact pharmacists were principally surveyed, most pharmacists were males. 
Pharmacists were also, on average, seven to 10 years younger than doctors and other providers (Table 3). 
 
 
ECP training  
Among the 315 providers in this study, one-third had been trained in FP in general and only 21 percent had 
been specifically trained in providing ECP. A relatively larger proportion of doctors, compared to other 
providers or pharmacists, had been trained in ECP, and more than half were trained after 2007 (Table 4). 
 
Table 4: Percent of providers trained on FP and ECP 
 
 
Ever received training in FP 
Qualified 
doctors 
Other 
providers 
Pharmacists Total 
67.5 63.6 12.1 32.1 
Ever received training in ECP 43.4 24.2 10.6 20.6 
Received brochures or any reading 
materials on ECP 
10.8 15.2 14.2 13.4 
Total (N) 83 33 199 315 
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Only 13 percent of providers reported receiving any brochures or other reading materials on ECP at any 
time, yet all of these providers reported having read the materials. The sources of these materials were mostly 
medical representatives, with some providers receiving them from NGOs, social marketing agencies, and the 
Ministry of Health.  
 
 
Table 5: Providers’ knowledge of ECP’s mechanism  
of action 
Mechanisms of action Total 
Inhibits ovulation 12 
Prevents Implantation 46 
Induces abortion 3 
Kills sperm 3 
Do not know 43 
Total (N) 315 
Note: Percentages may not add to 100 because of multiple responses 
Knowledge of ECP mechanism  
Almost half of providers believed that ECP 
prevents implantation, while 12 percent felt ECP 
inhibits ovulation. A large proportion reported not 
knowing how ECP prevents pregnancy (Table 5). 
The latest literature on ECP states that it does not 
prevent implantation in any way (FIGO and ICEC 
2012), and thus this belief, largely held by doctors, 
needs to be addressed and corrected. 
 
Qualified doctors were relatively more knowledgeable among providers interviewed, probably because more 
of them have received technical education on ECP, whereas pharmacists were the least knowledgeable. It is 
important to note that 61 percent of pharmacists did not know how ECP works. Almost all providers (96%), 
however, mentioned that ECP needs to be taken within 72 hours of unprotected sexual intercourse, largely 
because of the guidelines for administration by healthcare providers of ECPs issued by India’s Ministry of 
Health and Family Welfare, which states “emergency contraceptive pills must be preferably taken within 72 
hours of an unprotected act of intercourse, the earlier the better” (MoHFW 2008). WHO’s guidelines which 
state that ECP can be taken within 120 hours. Following MoHFW guidelines, national advertising (when 
permitted) also endorsed ECP use within 72 hours rather than 120 hours.  
 
Figure 1: Providers’ knowledge of ECP’s mechanism 
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A question on whether providers thought ECP is an abortifacient revealed that two-thirds knew ECP is not 
an abortifacient, while 16 percent thought it is; 18 percent were unsure. Variations according to provider type 
were discernible: 90 percent of qualified doctors and 72 percent of other providers said ECP is not 
abortifacient, while only 55 percent of pharmacists knew it is not. Conversely, more pharmacists (20%) than 
other providers (12%) and qualified doctors (10%) believed it is an abortifacient, with one quarter of 
pharmacists unsure. 
 
 
Women eligible for ECP  
Only 18 percent of providers mentioned that any woman is eligible to use ECP. Although more than half 
(59%) of providers said adolescent or unmarried women could use ECP, a large majority (80%) felt married 
women are most eligible for using ECP (Table 6). 
*Percentage adds to more than 100 because of multiple replies 
Table 6: Providers’ opinions on who can use ECP* 
ECP Eligibility  
 
Qualified 
doctors 
Other 
providers 
Pharmacists Total 
Married women 78.3 90.9 79.4 80.3 
Adolescent/unmarried women 60.2 39.4 61.8 59.0 
Rape survivors  20.5 6.1 3.0 7.9 
Any women 24.1 12.1 17.1 18.4 
Others 0.0 0.0 1.0 0.6 
Do not know 0.0 0.0 1.5 1.0 
Total (N) 83 33 199 315 
 
Further questioning on the circumstances when ECP is appropriate shows that providers accept a number of 
situations in which ECP could be useful and appropriate (Table 7). 
Table 7: Providers’ opinions on circumstances when ECP is appropriate 
 
 
Qualified Doctors Other Providers Pharmacists Total 
Rape or sexual coercion 26.5 9.1 11.6 15.2 
Infrequent/unpredictable 
sex 
61.4 60.6 51.8 55.2 
Engage in sex work 7.2 3 9 7.9 
Unprotected sex 41 27.3 15.1 23.2 
Living in refugee/conflict 
setting 
7.2 6.1 1 3.2 
Contraceptive failure 12 12.1 6.5 8.6 
Others 2.4 0 1.5 1.6 
Do not know 0 0 0.5 0.3 
Total (N) 83 33 199 315 
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When asked whether there should be a minimum age for ECP provision, most providers (73 to 94%) favored 
minimum age restriction for ECP (Table 9). When asked further on which age minimum, answers ranged 
from 14 to 45 years. Only approximately 14 percent of providers overall, more so among pharmacists (17%), 
felt no need for age restrictions. 
Table 8: Providers’ view on minimum age for ECP (percent) 
 
  Qualified doctors Other providers Pharmacists Total 
Should there be a minimum 
age restriction for ECP? 
Yes 84.3 93.9 73.5 78.5 
No 12.0 3.0 17.0 14.2 
Cannot say 3.6 3.0 9.5 7.3 
Total (N) 83 33 199 315 
Over 40 percent of respondents mentioned the ages of 14 to 18 as minimum age for ECP provision, while an 
almost equal proportion (39%) recommended 19 to 24 years; around 16 percent suggested the age of 25. 
Disintegrated data show that the majority (32%) of providers believed the age of 18 should be the minimum 
for providing ECP; interestingly, 18 is also the minimal legal age of marriage for girls. Another one-fifth 
recommended 20 years as the minimum age for providing ECP.    
Table 9: Providers’ view of minimum age for ECP use (percent*) 
Minimum age  
for ECP 
Qualified 
doctors 
Other providers Pharmacists Total 
14 - 18  27.1 29 49 40.5 
19 - 24 28.6 41.9 35.4 39.3 
25 years + 24.3 29 15 19.8 
Total (N) 70 31 147 247* 
*Based on responded who favored age restriction for providing ECP 
 
Safety and effectiveness of ECP and contraindication knowledge  
The vast majority of providers believed ECP is safe and effective in preventing pregnancy: 
Table 10: Providers’ opinions of ECP’s safety and effectiveness  
Opinion 
Qualified 
doctors 
Other 
providers 
Pharmacists Total 
Safety 
Believed ECP is safe 
 
88.0 
 
97.9 
 
84.3 
 
85.7 
Effectiveness     
Very effective 72.3 81.8 86.8 82.4 
Somewhat/not effective 26.5 12.1 7.6 13.1 
Do not know 1.2 6.1 5.6 4.5 
Total (N) 83 33 199 315 
 
Questions about ECP’s medical contraindications revealed various misconceptions and a lack of correct 
knowledge among providers. According to WHO’s Medical Eligibility Criteria, ECP is safe in all conditions, 
except pregnancy (2009). Less than two percent of providers stated that there are no conditions under which 
ECP is unsafe, and many doctors and other paramedics held misconceptions that ECP cannot be taken by 
women suffering from heart disease or who are breastfeeding (Table 11). Over one third of providers, 
including over half of pharmacists, reported a lack of knowledge on ECP medical eligibility criteria. 
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Table 11: Knowledge of ineligibility criteria (for not using ECP) (percent) 
  Qualified doctors Other providers Pharmacists Total 
No medical conditions 3.6 0.0 0.5 1.3 
Pregnancy 59.0 48.5 31.2 40.3 
Liver diseases 45.8 33.3 10.1 21.9 
Heart diseases 37.3 42.4 12.6 22.2 
Breastfeeding 26.5 15.2 6.0 12.4 
Weakness/nausea/lack of hemoglobin/others 1.2 6.1 3.5 1.9 
Do not know 0.0 30.3 52.8 36.5 
Total (N) 83 33 199 315 
Note: Percentages add more than100 because of multiple responses 
 
 
Provider attitudes of ECP provision as OtC or prophylactic drug 
A little more than half of the providers agreed that women should be provided ECP in advance of sexual 
intercourse to be used when required (Table 12). However, more doctors than other providers and 
pharmacists did not support providing ECP on a prophylactic basis. A logistic regression analysis showed that 
male providers were three times more likely than female providers (OR = 3.51, p < 0.05) to support 
provision of ECP on a prophylactic basis, as were younger providers (OR = 1.93, p < 0.01), those who had 
ever received training in FP (OR = 1.99, p < 0.05) and those who had ever received any brochures or other 
educational materials on ECP (OR = 2.37, p < 0.05). 
 
 
Table 12: Provider attitudes and beliefs about ECP access and availability (percent) 
  Qualified 
doctors 
Other providers Pharmacists Total 
Should women be 
provided with EC in 
advance of sex? 
Yes 48.2 57.6 58.1 55.4 
No 42.2 27.3 19.7 26.4 
Do not know 9.6 15.2 22.2 18.2 
Should EC be 
available OTC 
without 
prescription? 
 
Yes 29.3 39.4 60.6 50.2 
No 67.1 60.6 34.3 45.7 
It depends 1.2 0.0 0.5 .6 
It is already an OTC drug 2.4 0.0 4.5 3.5 
 Total (N) 83 33 199 315 
A similar probing on whether ECP could be provided OtC shows that more doctors and other trained 
providers than pharmacists were against provision of ECP as an OTC drug. A logistic regression analysis 
showed that male providers were three times more likely than female providers (OR = 3.5, p < 0.01) to 
support availability of ECP as an OtC drug. No other characteristics showed any significant difference on 
provision of ECP as an OtC drug, though generally less than one-third of the doctors supported provision of 
ECP as an OtC drug. 
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Stock out and other challenges in providing ECP 
Slightly less than half (44%) of providers, mainly from NGOs and urban public health FP clinics, as well as 
pharmacists mentioned occasional stock outs, while 35 percent of all providers said they never experience any 
stock outs. Ninety-two percent of providers said they do not have any ECP supply problems, however. Only 
30 percent of providers felt all ECPs currently available in the market are of good quality, and 32 percent felt 
ECP’s current cost is affordable. 
 
 
Preferred ECP providers  
When asked who should provide ECP, qualified doctors (96%), followed by pharmacists (63%), were 
mentioned most frequently. Only a quarter of providers interviewed mentioned nurses or midwives, and still 
a smaller percent (16%) mentioned CHWs or local TBAs or village doctors (5%) as preferred sources of 
ECP. Bivariate analysis further suggests that a significantly higher proportion of male providers (74%) than 
female providers (46%) agree with making ECP available to all women through CHWs (z test, p<0.01). 
In rural areas, CHWs such as ASHAs and (unqualified) village doctors could play a significant role in ensuring 
easy ECP accessibility to all who need it. Nevertheless, this study’s findings study show that two-thirds of 
doctors are still resistant to ECP provision through CHWs or other non-medical providers. 
 
 
Characteristics of ECP seekers 
Most providers mentioned that the majority of women seeking ECP from them are between 20 and 29 years 
old, with one-third of providers reporting women aged between 30 and 39 years old (Table 13). Ten percent 
of providers reported providing ECP to women under 19, primarily by pharmacists. As to be expected with 
these age profiles, the majority of providers reported most ECP clientele as married, while nearly half 
reported unmarried or student clientele. A small proportion of providers also mentioned men approaching 
them for ECP information or other services. 
 
Table 13: Impressions of providers who use ECP (percent)* 
Age Range Seeking ECP 
Qualified 
doctors 
Other 
providers 
Pharmacists Total 
<=19 years 1.2 3.0 15.6 10.5 
20-29 years 68.4 74.2 81.9 77.7 
30-39 years 39.2 58.1 31.7 36.2 
40 years and more 0.0 6.5 2.5 2.3 
Women of all ages 2.5 0.0 6.0 4.5 
Total (N) 79 31 199 309 
ECP Seekers’ Status     
Married women 68.4 87.1 55.8 62.1 
Students/unmarried women 20.5 30.3 60.3 46.7 
Women of all ages 15.2 3.2 28.1 22.3 
Men 5.1 3.2 13.6 10.4 
Do not know 2.5 0.0 2.5 2.3 
Total (N) 79 31 199 309 
*Based on those currently providing ECP 
 
Table 12 indicates that unmarried younger women or students are more likely to go to pharmacies, whereas 
married older women are more likely to go to other providers; younger, unmarried women are least likely to 
go to qualified doctors. 
 
 
Repeated use 
More than three-fourths of doctors, along with almost half of other providers and one third of pharmacists, 
felt ECP should not be used repeatedly in the same menstrual cycle. Large proportions of pharmacists and 
providers other than doctors did not know whether ECP could be used repeatedly in the same menstrual 
cycle. (Figure 2: N=315). 
 
Figure 2: Providers’ opinions on repeated use within one menstrual cycle 
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Among the 41 providers who felt ECP could be used more than once in the same cycle, the majority 
recommended a limit of two times during the same menstrual cycle. About three-fourths (72%) of 
pharmacists and more than half (57%) of doctors believe that “many women” use ECP repeatedly.    
 
Two-thirds of pharmacists (131 of 199) have provided ECP to the same woman more than once, but not 
necessarily in the same cycle, while only 16 percent of doctors (out of 83) and 24 percent of other providers 
(out of 33) reported doing so. Furthermore, over half (56%) of all providers said a small proportion (10%) of 
women who come to them have taken ECP before. A substantial proportion (14%) of the 131 pharmacists 
reported that more than 30 percent of women they serve have received ECP from them more than once 
(Table 14).  
 
Table 14: Percentage of women buying ECP more than once (percent) 
 Percent Qualified doctors Other providers Pharmacists Total 
 1-10 84.6 75 52.7 56.6 
11-20 7.7 12.5 26.7 24.3 
21-30 7.7 12.5 6.9 7.2 
31 percent or more  0.0 0.0 13.7 11.8 
 Total (N) 13 8 131 152 
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Need for guidance on repeated use  
Slightly less than half (44%) of providers felt there should be guidance on the number of times a woman 
could use ECP in the same month, but opinion varied widely: 70 percent of doctors, 49 percent of other 
providers, and 33 percent of pharmacists believed guidance on repeated use should be provided.  
 
 
ECP users’ preferred brands 
Figure 3 shows, among different ECP brands on the market, Unwanted-72 (82%) and I-pill (74%) are the two 
most commonly provided.  
 
Figure 3: Types of ECP dispensed by providers 
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Information provided to customers requesting ECP   
As seen in Table 15, nine out of 10 pharmacists reported simply providing ECP to customers. Half of doctors 
said they provide general information on ECP, and were more likely than other providers and pharmacists to 
explain when and how to use ECP, its various side effects, and to counsel them on other FP methods. 
 
Table 15: Service and information provided to customers requesting ECP (percent)* 
Information provided to customers 
Qualified 
doctors 
Other 
providers 
Pharmacists Total 
Simply ECP 2.5 12.9 93.5 62.1 
General information 51.9 54.8 4.5 21.7 
How to use 46.8 32.3 2.5 16.8 
When to use 53.2 35.5 2.0 18.4 
About side effects 34.2 22.6 1.0 11.7 
Counsel on FP 17.7 3.2 0.5 5.2 
Counsel on STI/HIV/respond to 
other queries/refer to other 
services 
16.5 9.7 2.5 6.8 
Total (N) 79 31 199 309 
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Provider Suggestions for IncreasIng ECP Knowledge  
A large majority (80%) of providers have observed a need for more media campaigns increasing public 
awareness of ECP. Providers recommended more advertisements on television (42%), mid-media campaigns, 
and meetings or posters (19%) to build ECP’s image as backup support for temporary FP methods. 
Awareness campaigns disseminating accurate ECP knowledge through health workers and doctors were also 
suggested. 
 
 
Findings from Key Opinion Leaders 
Knowledge of mechanism of action 
All eight gynecologists knew ECP’s mechanism of action, stating that ECP works by delaying or inhibiting 
ovulation, as is reflected in the following quote: 
“The precise mechanism of how ECP works in a particular case is unknown. The action of ECP depends on 
time taken (after unprotected sex) and the stage of menstrual cycle. The mechanisms of action are that ECP 
delays ovulation, thickens the cervical mucus, directly inhibits fertilization and alters transportation of egg and 
the sperm.” —Senior gynecologist, public hospital  
 
Uncertainty and ambiguity about ECP’s mechanism of action persists among providers; for instance, ECP’s 
effect if taken after ovulation or implantation was unclear to many. One doctor stated:  
“The exact mechanism of action is not known. But it mainly prevents ovulation and it depends what day of a 
menstrual cycle ECP is taken.” —Senior official, Indian Medical Association  
 
Less than half of interviewed KOLs clearly stated that ECP is not an abortifacient, but the other KOLs also 
seemed to think ECP is not abortifacient as well.  
 
Safety 
All 19 KOLs regarded ECP as safe, with eight stating that ECP is safe but with minor side effects: 
“There are no health hazards with this pill, because it is a progesterone pill; and progesterone is a hormone in 
the body. You will not have any major problem if you take EC, apart from menstrual irregularity and maybe 
some breast tenderness and abdominal pain.” —Senior official, national family welfare program  
“There are not major issues concerning safety, except that some clients may experience minor side-effects, but 
there are no major side-effects.” —Program manager, international donor agency 
 
Effectiveness 
Six KOLs stated that ECP’s effectiveness is more than 90 percent, with two stating more than 80 percent 
effectiveness, and one mentioning 60 to 80 percent effectiveness; the remainder mentioned that ECP is “very 
effective” but did not give an exact figure. Six medically-trained informants, however, mentioned that ECP’s 
effectiveness varies according to whether it is taken before or after ovulation, and how long after the sex act:  
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“The effectiveness of ECP is time bound. If you take it in the first 24 hours it is very effective and if you take 
it in the next 24 hours it is less effective. In general if you take it within 72 hours, I would say it is 85 
percent effective.” —Senior gynecologist, private hospital 
 
 
Attitudes Towards ECP 
Appropriate ECP use 
Eight of 19 KOLs stated that the most common situation in which ECP could be used was contraceptive 
failure: 
“No contraceptive method is 100 percent effective. So you need a backup method like ECP, in case a woman 
misses a pill, or there is condom rupture.” —Senior gynecologist, public hospital  
 
ECP was also regarded as appropriate for women who have infrequent sexual intercourse: 
“It is a better option for women whose husbands are migrants.”  
—Program manager, international donor agency 
 
“I think unmarried girls who are exploring their sexuality and having infrequent sex with their boyfriends 
can use it.”—Senior gynecologist, private hospital. 
 
Less than half (7 of 19) felt ECP is appropriate for all women, irrespective of marital status and age: 
“There is nothing like that ECP is appropriate for certain kinds of women. It is for all women.”  
—Senior official, Indian Medical Association  
 
 
Link with promiscuity and premarital sex 
Only three KOLs linked increasing ECP’s access to promiscuity and premarital sex. For most KOLs, it was 
either a misconception, or they stated that premarital sex will occur with or without ECP, although six were 
unsure or did not directly disclose an opinion.  
“I don’t think there is any correlation between promiscuity and premarital sex. People will continue to what 
they want to do, but this comes as a handy tool in certain situation. ECP is what it says … it is an 
emergency contraceptive pill … it is for an emergency.”  
—Senior program manager, pharmaceutical manufacturing company 
 
 
Belief that ECP will supplant regular contraceptive methods  
Half of KOLs said increased ECP availability will not make it a substitute for regular methods, as those using 
a method regularly will continue and not shift to ECP, if they are satisfied with their regular method; the cost 
of repeated ECP use is higher, and it is less effective. Two gynecologists and one FP officer mentioned that 
most clients shift to regular methods after using ECP because of counseling, but in their experience, a few do 
not transition to regular methods, primarily because of misconceptions about regular methods,                     
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or because their partners do not want to use condoms or they find ECP more convenient because they have 
irregular sexual intercourse. 
“In my experience, if 10 women have taken EC and are counseled for regular method use after that, then 
eight would go for regular method while two would not. The main reasons why they do not want to use a 
regular method are because of misconceptions, like their weight will increase if they take OCPs or it may 
cause cancer.” —Senior gynecologist, public hospital and senior official, medical association 
 
Conversely, eight of 19 KOLs expressed fear that increasing access to ECP will encourage people abandon 
regular contraceptive methods:  
“Personally I am against ECP. I do feel that it would result in the substitution of mala-D and condoms 
which is the best choice in case of contraceptives.”  
—Senior program officer, State Health Resource Center 
 
 
Reservations among providers and program managers 
Half of KOLs said that doctors and paramedics may have some reservations in providing ECP. Three KOLs 
believed ECP requires a lot of counseling for countermanding its misuse and that doctors do not have the 
time, so they are not able to promote it actively: 
“Our doctors have no time or habit of counseling on ECP or any health issue for that matter.”  
—Program manager, national health and FP NGO 
 
Three informants said, since ECP is easily available and accessible as an OtC drug, women misuse it, as a 
regular FP method, and then rush to the gynecologist when it is too late, either when they have become 
pregnant or their menstrual cycle has become irregular. Hence, even if ECP is an OtC drug, it was felt that 
women who use it should visit a gynecologist after use. 
A few gynecologists and a top state family welfare officer believed ANMs should not promote ECP because 
of its potential misrepresentation as an abortion pill: 
“Some gynecologists have personally told me that they feel ANMs should not promote ECP because they will 
misuse it. They fear that as ANMs do private practice and they may sell the [free] ECP as an abortion pill.  
Nor ANMs are trained enough to provide it.”  
—Senior program manager, state family welfare program 
 
Two mid-level state program officers mentioned that the government’s FP program is perceived as low 
priority, even by top officials and, hence, many important activities are neglected. For example, no one has 
inquired about how ECP is being introduced in rural areas, nor how ANMs or ASHAs have been oriented on 
ECP. A program manager from a large donor agency felt that government officials may also have reservations 
about increasing ECP access because of moral issues or indifference about the method: 
“There might be some individuals [in the government] who might be skeptical of promoting ECP, having the 
notion that it would promote promiscuity. We know that easy access of ECP does not promote promiscuity 
but some government officials might be holding value judgments. If higher level officials don’t talk about it, 
then the message goes down the line.” —Program manager, UN agency 
 
ECP users  
KOLs felt that government hospital clients are mostly married women, parity one and two, under 30, and of 
lower income, with most using ECP either because of method failure or infrequent relations with their 
husbands:  
“Women whose husbands are not living with them come to us for ECP. Their husbands are posted in Tamil 
Nadu or and come infrequently to Delhi. They use EC pills. Ours is a government set up, most of the women 
who come are mostly married middle class women.”  
—Senior gynecologist, public hospital and senior official, medical association 
  
Clients at large private hospitals are generally single, sexually active women, between the ages of 18 to 26 (i.e. 
before marriage), from the upper middle and upper class, well educated, and with infrequent sexual 
intercourse. Many face menstrual-related problems or have failed to protect themselves from pregnancy. 
Most unmarried women from lower-middle income groups go to private clinics if they can afford the cost. 
Some KOLs consider ECP as a symbol of women’s empowerment. A senior gynecologist stated: 
“I believe it is a very a safe product and it empowers the woman and it’s a felt need. They only come to me 
when they face some problem” —Senior gynecologist, private hospital 
 
 
Attitudes Towards Repeated Use Table 16: Definition of repeated ECP use,  
reported by key opinion leaders 
Number of times in a month qualifying 
as repeated use 
Frequency 
1 5 
2 4 
3 3 
Can’t say*  7 
Total (N) 19 
*Includes 1 missing case 
Definition of repeated use 
As shown in Table 16, over one-third of KOLs 
could not say how many times ECP can be taken 
in a menstrual cycle before considered as 
repeated use. Almost all KOLs interviewed, 
however, were concerned about repeated use, of 
the view that ECP is for emergency and should 
be a last effort to protect from unwanted 
pregnancy. 
 
Fear of ECP repeated use  
One of the biggest concerns often expressed, with as many as 13 of the 19 KOLs expressing serious concern, 
is that ECP is not being used as an emergency pill, nor is it advertised or promoted as such: 
“If a woman is taking ECP five times it means she needs to use a regular contraceptive. The amount of 
progesterone taken in five times of ECP use is more than the one month’s pack of OCP. The client needs to 
understand this; moreover, suspecting unwanted pregnancy five times a month means a lot of stress and 
tension. If she is taking it once every month and then it is not an emergency either. ECP is for real 
emergency.” —Senior gynecologist, public hospital and senior official, medical association  
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“An emergency does not repeat frequently. If you put your hand in the fire, you don’t do it again, do you? 
Why talk about repeat use? We can’t keep talking about how many times to use it repeatedly. You can’t get 
in to an emergency every now and then. We have to talk about ECP in a different fashion. This is an 
emergency pill- the message should be to use it during an emergency and then go on to a routine method.”  
—Senior official, national family welfare program 
 
 
 
Over the Counter ECP Provision  
Concerns of side effects and failure following OtC ECP provision  
Gynecologists reported that women come to them after they have already purchased ECP OtC, either with 
side effects (irregular bleeding) or pregnant. Gynecologists’ main concern is their lack of opportunity for 
counseling women since ECP is an OtC drug.  
“My only issue is that there should be a rider on ECP pack that the client should follow up with a 
gynecologist within 15 days of taking it, and then we can counsel women on the failure rates. What usually 
happens is that it is a progesterone pill and the user has a little bit of bleeding and confuses it as a normal 
period. But actually they have missed their period and when they come to us, they come with an advanced 
pregnancy.” —Senior gynecologist, private hospital  
 
Five KOLs voiced concerns with making ECP an OtC drug:  
“I strongly feel that ECP should be distributed only through doctor’s prescriptions. It should not be available 
over the counter for anyone to buy. That is how it is being hugely misused. Anyone anytime could go and ask 
and buy it from a chemist any number of times.” 
—Senior program officer, State Health Resource Center  
“Repeat use of ECP is a concern when we are trying to expand the use of OCPs and condoms.”  
—Program manager, international donor agency 
 
Four KOLs said, if ECP is an OtC drug, that public awareness about its proper use is needed: Providers 
should be adequately trained and ECP packaging should be properly informative or a proviso should 
recommend users see a gynecologist after self-administering ECP. 
 
Could ECP help decrease abortions?  
Many gynecologists (6 of 9) said it seems logical that increasing ECP’s access could have led to a decline in 
abortions; they felt sure number of surgical abortion has decreased but did not have supporting statistics. For 
example: 
“The number of young girls who used to come for abortion has declined. In my own clinic, there used to be two 
to three girls every week with unwanted pregnancy for abortion and they would be 10 to 12 weeks pregnant. 
Now in a month we hardly see one such girl. So ECP has prevented unwanted abortions”  
—Senior gynecologist, famous private hospital 
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“Surgical evacuations have gone down a lot. One is because of ECP and second because we are giving them 
medical abortifacient. The number of surgeries we are doing has drastically dropped. But we cannot say if it is 
because of ECP or the MTP pill.” —Senior gynecologist, private hospital 
 
 
Supply, Demand, and Access  
Barriers to women’s access  
Five KOLs stated there are no barriers to women’s ECP access. 
“Getting ECP is not a problem as it is an OtC drug.  You can go to an unknown chemist if you want 
privacy. Even the cost [of Rs. 100] is not much.” —Senior gynecologist, public hospital 
 
Many KOLs (7) believe the main barrier is a lack of real ECP knowledge and its correct use. Some said that 
there is no awareness among rural women that ECP exists. Three informants mentioned that, in smaller 
towns and villages, the fear and stigma associated with acquiring ECP also poses a barrier:  
“There is stigma and fear attached to access EC. If a woman wants to get ECP and does not want her 
husband to know, then how will she ask for it? She will think what people will say. It is important to take 
health workers in confidence.” —Senior official, medical association 
 
Two KOLs mentioned there has not been enough provider training, which prevents access, while another 
two said cost also restricts ECP access. 
 
Provider challenges  
Several challenges were reported, including lack of knowledge, inadequate training, difficultly in identifying 
clients, and counseling them, meager motivation, and poor supply in public clinics. Over half the KOLs said 
providers, including doctors, pharmacists, and ASHAs and ANMs, do not have accurate ECP knowledge nor 
have been adequately trained to provide ECP and related services; it should be noted that no ECP training 
was offered when introduced by the government.  
“All the training guidelines have been developed for ASHAs, but somebody has to take the pain to train 
them and explain them about ECP and monitor usage. You are talking about eight lakhs ASHAs and 
thousands of trainers, so training looks like an issue.” —Program manager, UN agency 
“None of the ANMs have got any training on ECP, they learnt by practice and by working with us and 
discussing with us. There has been no training given to any doctors or ANMs or to the pharmacists. It is also 
not there in the service guidelines of doctors or ANMs. Then how will anyone know about the exact or the 
appropriate use of ECP?” —Gynecologist, urban family planning clinic 
“The pharmacists are not trained and they just give ECP on demand. How will they counsel and give correct 
information to the client?” —Senior gynecologist, private hospital 
 
Four program managers reported that ECP, and even FP, provision has not been a focus of the Department 
of Health and Family Welfare:  
“Family planning has never been a focus. No high profile official wants to inaugurate meetings of the family 
planning program. ECP has not been a focus since it was never there in supply. Now it has come back and 
the supply is picking up. People are asking for it. FP is low priority in the State health system”  
—Senior program manager, state family welfare program   
 
Five informants mentioned that there is little chance for ECP counseling, either because doctors are not in 
the habit or because it is purchased OtC without doctor consultation. Nine KOLs mentioned special 
challenges for increasing access to ECP in rural areas:   
“In rural areas people have to travel 10 kms to reach a pharmacist, unlike in urban areas. There is no bus 
or any transport to reach there. Cost is also a barrier. Also there is a certain degree of anonymity in urban 
areas but in rural areas everyone will come to know if you are buying ECP. It is a challenge to reach these 
groups.” —Program manager, national health and FP NGO 
 
Opinions of the ASHA pilot project 
In general, program managers welcomed GoI’s pilot project to make ASHAs contraceptive depositories for 
community supply at a small cost. While one informant believed that charging Rs.2 for ECP from ASHAs 
(instead from health facilities for free) may compromise access become those in dire need of ECP may not be 
able to buy it, another informant the price is not much and that making ASHAs depositories will increase 
ECP accessibility. The government’s ASHA pilot project was seen as focusing on spacing methods:  
“For the first time the government is going with a spacing package. It is a deviation from the earlier 
approach which focused on permanent methods. The supply will be at the district level and will not be 
withdrawn from there. The cost of Rs.2 for ECP is not much- money is not a big dampener. But training 
has to be done, a communication plan should be there and proper monitoring has to be done.”  
—Program manager, UN agency 
 
KOLs’ suggestions for increasing access  
As shown in Box 1, the key recommendations for 
increasing ECP access were the development of a 
communication plan and use of mass media for 
disseminating information to the public, 
particularly on repeated use, side effects, and 
emergency use only. It was also suggested that 
doctors, pharmacists, and CHWs providing ECP 
need to be adequately trained. Other suggestions 
for increasing access to ECP include frequent 
ECP updates circulated among government 
officials, inclusion of ECP information in all 
ANM and ASHA refresher courses, partnerships with rural private providers, and other forms of media 
including door-to-door counseling, IEC, and VHNDs for disseminating ECP information. The focus should 
be on adolescents and young people who can be reached through programs, sex education classes at school, 
the mass media and other forms of media (internet). Only one KOL said that ECP should be made available 
only on doctor’s prescription and not as an OtC drug. 
Box 1: Key recommendations  
for increasing ECP access  
• BCC plan including mass media  
• Adequate training of pharmacists  
• Adequate training of ASHAs 
• Regular and frequent updates on ECP  
for government officials 
• ECP should be included in refresher courses 
for ANMs 
• Sensitize mass media to project ECP 
correctly.  
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KOLs’ suggestions for advertising  
The key advertising message, according to 13 KOLs, should be ECP’s use for emergency situations only. 
ECP should be promoted along with other contraceptive methods, not as a separate method, in mass media, 
as a backup to method failure and with repeated use’s side effects given more attention. KOLs believe sex 
should be projected as a responsible and not casual activity for which ECP is readily available; informants said 
that this was one of the reasons why recent commercial advertisements were banned or withdrawn. Central 
government officials stated that ECP is being advertised in mass media, but state officials said it has yet to 
begin at their level. Many KOLs reiterated that a responsible role by media can help increase correct ECP 
information and knowledge; the media needs to be sensitized.  
 
“[Initially] ECP was being advertised as something very attractive to use. But it is not like that. The way we 
create awareness, educate and counsel the public and the providers is very important. It should be done in such 
a way that it is something that should be used only in accidents or emergency. It should not be advertised as a 
contraceptive method.” —Senior gynecologist, public hospital  
“The media is glorifying sex and making it sounds like a casual thing. It projected ‘let’s go have sex and take 
ECP after that’. They did not give the whole message and trivialized issue of unwanted pregnancy and risk of 
unsafe sex. Creating hype is the easiest thing to do. The media needs to show sex as a responsible behavior. 
We need sustained mass media, mid media and IPC to spread correct information to the public.”  
—Senior official, national family welfare program 
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Conclusions and Recommendations 
This study’s findings show that most providers, including doctors and some KOLs, were incorrectly informed 
about ECP’s mechanism of action. Many doctors still believe ECP prevents implantation and cannot be used 
by breastfeeding women or those with heart problems. Pharmacists, who provide most of India’s ECP, are 
the most uninformed group of providers. As a consequence of pharmacists’ lack of knowledge of ECP, they 
do not provide any information on it to customers, in addition to fear of embarrassing customers because of 
lack of privacy in their shops, in addition to lacking time for any real client counseling. It is encouraging that 
all categories of providers and KOLs generally believe ECP is safe and effective for preventing unwanted 
pregnancies. Most providers are still reluctant to provide or promote ECP as a prophylactic, and most KOLs 
said ECP is only appropriate for emergencies such as contraceptive failure or infrequent or isolated sex acts. 
Most providers believe ECP is best and most appropriate for married women and that a minimum age 
restriction of 18 to 20 should be instituted for ECP provision. The stigmatization of ECP makes its 
accessibility difficult and belies a general fear among providers of ‘misuse’ by young, unmarried women.  
 
Among all providers, ambiguities persist about the definition of repeated use during the same menstrual cycle. 
In general, repeated use of ECP was not acceptable among providers, including pharmacists, the primary 
providers of ECP, who believe many women use it repeatedly; pharmacists, compared to other providers, 
report more frequent, repeated ECP use by their clientele. Correct ECP use, including as a back-up method, 
depends largely on how knowledgeable users are, and in the absence of such knowledge incorrect use may 
cause menstrual disorder or pregnancy prevention failure. Service guidelines are necessary for accurate and 
adequate information on ECP’s mechanism of action, as well as its use as a back-up or emergency method, its 
frequency of use in the same menstrual cycle, and lack of effectiveness and possible side effects if used 
repeatedly.  
 
Most KOLs supported ECP’s continuation as an OtC drug, but some KOLs and many qualified doctors had 
reservations about promoting or mainstreaming ECP with other contraceptive methods; these same providers 
were also less supportive of its OtC status as well as its distribution by CHWs such as ASHAs. In general, 
doctors do not agree with ECP’s de-medicalization and would prefer it to be a prescription drug, which is a 
matter of concern requiring advocacy to influence and change their opinions. Disseminating accurate ECP 
information among all provider categories could be achieved, to some extent, by including ECP in the 
training curricula of all doctors, nurses, and pharmacists. Periodic seminars and presentations through the 
official organizations of different providers such as the Indian Council of Medical Research (ICMR), 
Federation of Obstetrics and Gynecological Societies of India (FOGSI), or Indian Pharmacists Association 
could also help mitigate misconceptions about ECP and improve dispensing practices for it.   
 
The most important rationale for ECP’s introduction and funding is that its easy access and correct use will 
reduce unwanted pregnancy and abortion. IDIs with doctors, however, belied their uncertainty about whether 
women are benefiting from ECP. Several senior gynecologists mentioned that ECP has helped reduce the 
rate of unwanted pregnancies and abortions, especially among young women, but they also stated this decline 
could be attributed to easy availability of medical abortion pills. 
 
Some providers and KOLs felt ECP’s benefits are undermined by irresponsible advertisements that result in 
misuse. There is a general feeling that young people are becoming more open to premarital sex, in which case 
ECP can prevent unwanted pregnancy, but it can be misused easily with too frequent use. Most KOLs 
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believe the relationship between ECP use and promiscuity is a misconception, although some do believe they 
are related. There is also concern that ECP may be substituted for regular contraceptive methods, but many 
KOLs believe it can act as a bridge to regular methods, if promoted correctly. 
 
Manufacturers, pharmacies, and some KOLs want the government to rescind the ban on ECP advertising but 
emphasize that advertisements should emphasize ECP’s “emergency only” use. ECP advertisements should 
emphasize its emergency utilization, when another method fails, rather than as a separate method. Several 
experts suggested responsible advertising through mass media and promoting ECP along with other 
contraceptive methods would help improve its perception as a back-up method among the general public and 
reduce misuse. Emphasizing that ‘any woman in an emergency situation can use ECP’ will also help reduce its 
stigma and the labeling of its users. As part of corporate social responsibility, medical representatives of 
different ECP manufacturing firms in regular contact with pharmacists could play a significant role in 
educating pharmacists about ECP and its overall role as an emergency device for protecting against unwanted 
pregnancy, and not as a regular method or abortifacient. 
22 
 
References 
Aksu H, O Başak, M Küçük, N Yeniçeri and S Kaya. 2011. Emergency Contraception: Knowledge, Attitude 
and Practice of the Pharmacy staff in Aydin, Turkey. Clinical Exp Obstetrics and Gynecologists 38 (3): 260-
264. 
Bhatnagar I and ME Khan. 2011. Increasing Acceptance of Spacing Methods in Rural Bihar: Implications for 
Behavior Change Communication. Policy Brief 5. New Delhi: Population Council. 
Blanchard K, T Harrison and M Sello. 2005. Pharmacists’ Knowledge and Perceptions of Emergency 
Contraceptive Pills in Soweto and the Johannesberg Central Business District, South Africa. 
International Family Planning Perspectives 31(4): 172-178. 
Camp SL, DS Wilkerson and TR Raine. 2003. The Benefits and Risks of Over-the-counter Availability of 
Levonorgestrel Emergency Contraception. Contraception 68: 309-317. 
Croxatto HB, V Brache, M Pavez, L Cochon, ML Forcelledo. F Alvarez, R Massai, A Faundes and AM 
Salvatierra. 2004. Pituitary-Ovarian Function Following the Standard Levenorgestrel Emergency 
Contraceptive Dose or a Ssingle 0.75mg Dose Given on the Days Preceding Ovulation. Contraception 
70: 442-450. 
Ehrle N and M. 2011. Emergency Contraceptive Pills: Knowledge and Attitudes of Pharmacy Personnel in 
Managua, Nicaragua. International Perspectives of Sexual and Reproductive Health 37(2): 67-74. 
Goel S, I Bhatnagar, ME Khan and A Hazra. 2010. Increasing Postpartum Contraception in Rural Uttar 
Pradesh. Journal of Family Welfare (Special Issue) 56: 57-64.  
INFO Project. 2007. Family Planning: A Global Handbook for Providers. Baltimore: INFO. 
International Institute for Population Sciences (IIPS). 2010. District-Level Household and Facility Survey 
(DLHS 3) 2007-2008: India. Mumbai: IIPS. 
International Federation of Gynecology and Obstetrics (FIGO) and International Consortium for Emergency 
Contraception (ICEC). 2012. Mechanism of Action: How Do Levonorgestrel-only Emergency 
Contraceptive Pills (LNG ECPs) Prevent Pregnancy? London and New York: FIGO and ICEC. 
Kishore V and MM Misro. 2010. Providers’ Knowledge, Attitudes, and Dispensing Practices of E-pills in 
Government Dispensaries of South District in Delhi, India. Indian Journal of Community Medicine 35(1): 
46-51.  
Lawrence RE, KA Rasinki, JD Yoon and FA Curlin. 2010. Obstetrician-Gynecologist Physicians’ Beliefs 
About Emergency Contraception: A National Survey. Contraception 82(4): 324-330. 
Ministry of Health and Family Welfare (MoHFW). 2008. Guidelines for Administration of Emergency 
Contraceptive Pills by Healthcare Providers. New Delhi: MoHFW. 
Nigam A, N Maheshwari and A Prakash. 2010. Knowledge of Emergency Contraception and Contraceptive 
Practices: Representative Study from Rural Uttar Pradesh. Indian Journal of Community Medicine 35(3): 
449-450. 
23 
 
Puri S, V Bhatia, HM Swami, A Singh, A Sehgal and AP Kaur. 2007 Awareness of Emergency Contraception 
Aamong Female College Students in Chandigarh, India. Indian Journal of Medical Science 61: 338-346. 
Rubin SE, S Grumet and L Prine. 2006. Hospital Religious Affiliation and Emergency Contraceptive 
Prescribing Practices. Research and Practice 96(98): 1398-1401. 
Sychareun V, K Phongsavan, V Hansana and A Phengsavanh. 2010. Policymaker and Provider Knowledge 
and Attitudes Regarding the Provision of Emergency Contraceptive Pills Within Lao PDR. BMC Health 
Services Research 10: 212.  
Tripathi R, AM Rathore and J and Sachdeva. 2003. Emergency Contraception: Knowledge, Attitude, and 
Practices Among Health Care Providers in North India. 
World Health Organization (WHO). 2005. Emergency Contraception. Fact Sheet 244. Available at 
http://www.who.int/mediacentre/factsheets/fs244/en, accessed December 22, 2011. 
World Health Organization Department of Reproductive Health and Research (WHO/RHR). 2009. Medical 
Eligibility Criteria for Contraceptive Use. 4th ed.  
World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns 
Hopkins Bloomberg School of Public Health/ Center for Communication Programs (JHUCCP), 
INFO Project. 2007. Family Planning: A Global Handbook for Providers. Baltimore and Geneva: CCP 
and WHO. 
Yam EA et al. 2007. Jamaican and Barbadian Healthcare Providers’ Knowledge, Attitudes and Practices 
Regarding Emergency Contraceptive Pills. International Family Planning Perspectives 33(4): 160-167. 
 
 
 
 
 
 
 
  
Appendix 
 
 
 
 
 
 
 
 
24 
 
25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
